Seven-Chemical Cocktail Rewinds Human Stem Cells to an Eight-Cell Embryonic State

In a development that could reshape how scientists study the earliest moments of human life, researchers in China have reported a chemical method for converting human pluripotent stem cells into cells that closely resemble those of a human embryo at the eight-cell stage. The work, published as a letter to the editor in Cell Research on 18 October 2026, describes a seven-chemical cocktail supplemented with leukemia inhibitory factor, dubbed 7CL, that reliably pushes cultured stem cells backward across a developmental boundary that has long proved stubbornly difficult to cross in the laboratory.

The biological target of the study is totipotency, the remarkable capacity of a cell to give rise to every tissue in the body, including both the embryo proper and the extraembryonic structures such as the placenta that are essential for a viable pregnancy. In mammals, true totipotency is fleeting. In humans it exists only during the earliest cleavage divisions after fertilization, and the moment of greatest importance arrives at the eight-cell stage, when the embryonic genome is largely switched on in a process known as zygotic genome activation. Because human embryos at this stage are scarce, protected by strict ethical and legal restrictions, researchers have sought ways to recreate eight-cell-like states in culture dishes using stem cells as raw material.

Previous efforts to generate such eight-cell-like cells, abbreviated 8CLCs, have taken several routes. One influential strategy used transient overexpression of DUX4, a transcription factor normally activated at the eight-cell stage, to nudge pluripotent cells toward a totipotent-like identity. Others relied on multistep chemical treatments, including a four-chemical cocktail with leukemia inhibitory factor known as 4CL, or on inhibiting the spliceosome, the cellular machinery that processes RNA, to produce totipotent blastomere-like cells in human and cynomolgus monkey cells. Each approach advanced the field, but all carried drawbacks that limited their usefulness.

The limitations were substantial. The 4CL protocol demanded nearly three weeks of continuous induction and yielded only around 10 percent of cells expressing TPRX1, a key marker of the eight-cell state. Spliceosomal inhibition, while enabling impressive functional evidence of totipotency-like behavior, produced populations whose efficiency and frequency were not fully characterized. Perhaps most fundamentally, many of these strategies judged success by a single marker such as TPRX1, which the authors argue cannot fully resolve whether the induced cells genuinely match the molecular fingerprint of natural eight-cell blastomeres or merely superficially resemble them.

To overcome these obstacles, the team, led by Xi Kong, Nan Jiang, Shaowei Chen and Xingyou Zhang under the supervision of Huangfan Xie and Bingqing Xie at Southwest Medical University and collaborating institutions in Sichuan, engineered a human pluripotent stem cell line carrying two fluorescent reporters. One reporter drives green fluorescent protein from the TPRX1 locus, the other drives a red fluorescent protein from ZSCAN4, another gene associated with early cleavage-stage embryos. This dual-reporter system allowed the researchers to watch, in real time and at single-cell resolution, exactly which cells converted and to isolate the double-positive population for deep molecular analysis.

With this tool in hand, the researchers performed systematic chemical screening to identify a combination capable of driving conversion efficiently. The resulting cocktail, 7CL, comprises seven small molecules together with leukemia inhibitory factor. Within just six days of treatment, roughly 51.5 percent of the cells expressed TPRX1, a fivefold improvement in yield over the earlier four-chemical protocol and a dramatic reduction in induction time from about twenty days to under a week. The speed and efficiency matter practically: shorter protocols reduce the opportunity for unwanted genetic and epigenetic damage to accumulate, and higher yields make downstream analyses and applications far more feasible.

Crucially, the team found that within the TPRX1-positive population there existed a transcriptionally refined subpopulation that also expressed ZSCAN4. When the researchers compared this double-positive population to genuine human eight-cell blastomeres using transcriptomic and epigenomic profiling, the correspondence was striking. The induced cells faithfully recapitulated both the gene-expression patterns and the chromatin-level features of their natural counterparts, suggesting that the 7CL protocol does not merely flip a marker gene but genuinely reconfigures the cellular regulatory landscape toward an eight-cell identity. Single-cell analyses, in which the gene activity of thousands of individual cells is charted, supported this conclusion by revealing a trajectory from primed pluripotency through intermediate states into a coherent eight-cell-like program.

The functional evidence is what elevates the work beyond molecular mimicry. When tested in vitro, the 7CL-induced cells showed the capacity to contribute to both embryonic and extraembryonic lineages, the defining functional property that distinguishes totipotent cells from the merely pluripotent stem cells from which they were derived. The authors also report in vivo contribution experiments, in which the induced cells were assessed for their ability to participate in tissue formation in living systems. Together these assays provide the kind of evidence that the totipotency field has increasingly demanded: not just the presence of eight-cell markers, but the demonstrated developmental plasticity that those markers are supposed to signify.

The implications reach across several domains of biology and medicine. A robust, chemically defined, six-day protocol for generating faithful eight-cell-like cells provides an unprecedented platform for studying zygotic genome activation, a process whose misregulation is thought to underlie some cases of early embryonic loss and infertility. Because the cells are generated without genetic manipulation of the type required for DUX4 overexpression, the protocol reduces concerns about genome alteration and offers a more translatable route. Large numbers of eight-cell-like cells could also serve as models for drug and toxin screening during the earliest window of embryonic development, a period that has been almost entirely inaccessible to direct experimentation in humans.

The study also refines the methodological standards of the field. By combining a dual-reporter system with transcriptomic and epigenomic validation, and by reporting yields explicitly rather than leaving efficiency ambiguous, the researchers offer a template for how totipotency-like states should be defined and verified. Challenges remain, including the incomplete characterization that still shadows some alternative approaches, the need to confirm the full developmental potential of induced populations, and the ethical questions that inevitably accompany any advance in engineering embryo-like cells. The work was supported by the National Natural Science Foundation of China and Sichuan provincial programs, and the authors report no competing interests. As chemical reprogramming continues to mature, the ability to rewind a mature stem cell to the earliest recognizable stage of human development promises to make one of biology’s most guarded secrets at least partially legible in a laboratory dish.

Subject of Research: Chemical induction of 8-cell-like totipotent states in human pluripotent stem cells

Article Title: Chemical reprogramming of human pluripotent stem cells into 8-cell-like states

Article References: Kong, X., Jiang, N., Chen, S., Zhang, X., Huang, A., Yi, S., Zhang, J., Yin, S., Peng, J., Jiang, Y., Xie, H., & Xie, B. (2026). Chemical reprogramming of human pluripotent stem cells into 8-cell-like states. Cell Research. https://doi.org/10.1038/s41422-026-01314-9

Image Credits: AI Generated

DOI: 10.1038/s41422-026-01314-9

Keywords: totipotency, human pluripotent stem cells, 8-cell-like cells, chemical reprogramming, zygotic genome activation, TPRX1, ZSCAN4, Cell Research, embryo model, stem cells, epigenomics, cell fate